Membrane technology

Outset Medical Welcomes Jean-Olivier Racine as Chief Technology Officer

Retrieved on: 
Wednesday, June 23, 2021

Outset Medical, Inc. (Nasdaq: OM) (Outset), a dialysis technology innovator, today announced the appointment of Jean-Olivier Racine as Chief Technology Officer.

Key Points: 
  • Outset Medical, Inc. (Nasdaq: OM) (Outset), a dialysis technology innovator, today announced the appointment of Jean-Olivier Racine as Chief Technology Officer.
  • Racine joins Outset Medical with more than two decades of experience in the technology industry.
  • I was drawn to join Outset Medical because of the vast opportunity the dialysis industry presents, especially with regards to utilizing technology and AI for the development of new care modalities, said Racine.
  • Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis.

Quanta Raises $245 Million to Accelerate Commercialization of its SC+ Portable Hemodialysis System

Retrieved on: 
Wednesday, June 23, 2021

Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care.

Key Points: 
  • Our small, simple-to-use, and powerful dialysis system SC+ is positioned to help transform kidney care.
  • The funding we are announcing today will allow us to accelerate our emergence as a significant force in this market.
  • With this growth capital, Quanta has the resources to drive improved patient outcomes and convenience while accelerating market penetration and scale.
  • Meanwhile, as a compact, portable and versatile device, SC+ provides flexibility to deliver dialysis across a wide range of use environments and prescriptions.

Repligen Corporation Announces Agreement to Acquire Polymem S.A.

Retrieved on: 
Tuesday, June 22, 2021

WALTHAM, Mass., June 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Toulouse, France based Polymem S.A. (Polymem), a leading industrial expert in the development and manufacture of hollow fiber membranes and modules.

Key Points: 
  • WALTHAM, Mass., June 22, 2021 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has entered into an agreement to acquire Toulouse, France based Polymem S.A. (Polymem), a leading industrial expert in the development and manufacture of hollow fiber membranes and modules.
  • Hunt, President and CEO of Repligen, said, We are delighted to have Jean-Michel, Franc and the Polymem team join the Repligen family.
  • Jean-Michel Espenan, President of Polymem, said, Since co-founding the company in 1997, Polymem has remained true to our expertise in hollow fiber membrane development and manufacturing for industrial and life sciences applications.
  • Perella Weinberg Partners LP is acting as financial advisor and Goodwin Procter LLP is serving as legal counsel to Repligen.

Global Water Scarcity and Hospitalization Rates Stimulate the Polymeric Membranes Market

Retrieved on: 
Tuesday, June 22, 2021

The demand for water treatment membranes and medical membranes will drive the global market, says Frost & Sullivan

Key Points: 
  • The demand for water treatment membranes and medical membranes will drive the global market, says Frost & Sullivan
    SANTA CLARA, Calif., June 22, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis of the global polymeric membranes market finds that the drive to achieve a circular economy and concerns about water scarcity encourage industrial and municipal stakeholders to adopt membrane-based systems for water and wastewater treatment.
  • This creates a surge in demand for membranes, such as water treatment membranes, wastewater treatment membranes, medical membranes, and industrial membranes across sectors.
  • As a result, the global polymeric membranes market is estimated to garner $9.01 billion by 2027 from $6.76 billion in 2020, an uptick at a compound annual growth rate of 4.2%.
  • Krishnanadded: "The rising demand for chemical-free solutions for water treatment in the food and beverage (F&B) and pharmaceutical sectors is expected to drive the market for water treatment membranes.

Global Water Scarcity and Hospitalization Rates Stimulate the Polymeric Membranes Market

Retrieved on: 
Tuesday, June 22, 2021

The demand for water treatment membranes and medical membranes will drive the global market, says Frost & Sullivan

Key Points: 
  • The demand for water treatment membranes and medical membranes will drive the global market, says Frost & Sullivan
    SANTA CLARA, Calif., June 22, 2021 /PRNewswire/ -- Frost & Sullivan's recent analysis of the global polymeric membranes market finds that the drive to achieve a circular economy and concerns about water scarcity encourage industrial and municipal stakeholders to adopt membrane-based systems for water and wastewater treatment.
  • This creates a surge in demand for membranes, such as water treatment membranes, wastewater treatment membranes, medical membranes, and industrial membranes across sectors.
  • As a result, the global polymeric membranes market is estimated to garner $9.01 billion by 2027 from $6.76 billion in 2020, an uptick at a compound annual growth rate of 4.2%.
  • Krishnanadded: "The rising demand for chemical-free solutions for water treatment in the food and beverage (F&B) and pharmaceutical sectors is expected to drive the market for water treatment membranes.

Top NIH Kidney Research Director Wins Prestigious Award from America's Premier Kidney Patient Group

Retrieved on: 
Monday, June 21, 2021

The 2021 Summit highlighted innovation in kidney biologics, diagnostics, and devices, and examined opportunities and challenges for accelerating treatment innovations in artificial kidneys, transplantation, and dialysis.

Key Points: 
  • The 2021 Summit highlighted innovation in kidney biologics, diagnostics, and devices, and examined opportunities and challenges for accelerating treatment innovations in artificial kidneys, transplantation, and dialysis.
  • The Summit was dedicated to the memory of former AAKP Board Member Brian Hess, a long-time advocate for kidney patient care choice and a champion of The Kidney Project, a KidneyX prize-winning initiative aimed at developing an artificial kidney ( read now ).
  • Richard Knight, AAKP President, former dialysis patient, and 14-year kidney transplant recipient stated, "This award recognizes Dr. Rodgers' relentless dedication to the kidney patient community, public service, and America's historic role as a leader in advanced research, medical innovation, and kidney care treatments.
  • About the American Association of Kidney Patients (AAKP): Since 1969, AAKP has been the largest kidney patient organization driving policy discussions on kidney patient consumer care choice and treatment innovation.

U.S. Renal Care Announces New Dialysis Center in Gloucester

Retrieved on: 
Thursday, June 17, 2021

PLANO, Texas, June 17, 2021 /PRNewswire/ -- U.S. Renal Care (USRC), a leading provider of dialysis, today announced that expanded services are available with the opening of a new center in Gloucester, NJ.

Key Points: 
  • PLANO, Texas, June 17, 2021 /PRNewswire/ -- U.S. Renal Care (USRC), a leading provider of dialysis, today announced that expanded services are available with the opening of a new center in Gloucester, NJ.
  • USRC staff are expertly trained in patient care and treatment options to ensure chronic kidney disease (CKD) patients understand options available to them, including dialysis, transplant, and palliative care.
  • "Whether in Marlton, Vorhees and now Gloucester, I'm confident my patients are getting the best possible overall kidney and dialysis care available."
  • Those interested in speaking with USRC staff about their kidney care and treatment options can contact the Gloucester center at (848) 2023080.

The Worldwide Polymer Nanomembrane Industry is Expected to Reach $1.1+ Billion by 2026 at a CAGR of 11.6% from 2021 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 16, 2021

The obtained polyacrylonitrile membrane displays high flux along with the required separation efficiency for various oil-in-water emulsions.

Key Points: 
  • The obtained polyacrylonitrile membrane displays high flux along with the required separation efficiency for various oil-in-water emulsions.
  • In the water & wastewater treatment industry, polymer nanomembranes are utilized as filtration membranes for reducing heavy metals, salt, nitrate, sulfate, and natural organic matter (NOM) content in water.
  • The growth in water & wastewater treatment is attributed to growing health awareness about the consumption of clean drinking water.
  • The demand for polymer nanomembrane in the US is expected to be driven by the modernization of existing water supply and wastewater treatment plants, along with investments for new facilities.

Global Polymeric Membranes Market Report 2021: Water Scarcity and Need for Circular Economies Drive the Industry - ResearchAndMarkets.com

Retrieved on: 
Tuesday, June 15, 2021

The "Water Scarcity and Need for Circular Economies Drive the Global Polymeric Membranes Market" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Water Scarcity and Need for Circular Economies Drive the Global Polymeric Membranes Market" report has been added to ResearchAndMarkets.com's offering.
  • This study presents an assessment of the global polymeric membranes market in 2020 and evaluates its future prospects.
  • The research analyzes the demand for polymeric membranes by end-use sector, separation process, and material.
  • Revenue and Unit Shipment Forecast, Polymeric Membranes Market
    Revenue Forecast by End-use Sector, Polymeric Membranes Market
    Unit Shipment Forecast by End-use Sector, Polymeric Membranes Market
    Revenue and Unit Shipment Forecast Analysis, Polymeric Membranes Market
    Revenue Forecast by Material Type, Polymeric Membranes Market
    Revenue Forecast by Separation Process, Polymeric Membranes Market
    Revenue Forecast Analysis by Material Type and Separation Process, Polymeric Membranes Market
    Revenue Forecast Analysis by Region, Polymeric Membranes Market
    Growth Opportunity 1 - Investment in Digitalization of Water and Wastewater Treatment for Increased Water Reuse, 2020
    Growth Opportunity 2 - Investment in Ion-Exchange Membranes to Accelerate Green Hydrogen Growth, 2020
    Growth Opportunity 3 - Investment in Blood Transfusion and Apheresis Membranes to Accelerate Revenue Growth, 2020

Satellite Healthcare Participates in Clinical Trial With Home Hemodialysis Machine

Retrieved on: 
Monday, June 14, 2021

Satellite Healthcare today announced it will participate in an ongoing clinical trial sponsored by DEKA Research & Development Corp. (DEKA).

Key Points: 
  • Satellite Healthcare today announced it will participate in an ongoing clinical trial sponsored by DEKA Research & Development Corp. (DEKA).
  • The study is investigating the clinical use of the HemoCare Hemodialysis System, a new home hemodialysis machine that has been designed by DEKA with a goal to make overnight hemodialysis safer and easier to perform.
  • We are proud to bring this opportunity to our dialysis patients in the Austin market, said Dr. Brigitte Schiller, Chief Medical Officer at Satellite Healthcare.
  • The trial, conducted with study partner CVS Kidney Care, will assess the safety and performance of the HemoCare Hemodialysis System.